Author Correction: Evaluating drug targets through human loss-of-function genetic variation

Affiliations

• ¹ Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA. eminikel@broadinstitute.org.
• ² Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA. eminikel@broadinstitute.org.
• ³ Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. eminikel@broadinstitute.org.
• ⁴ Analytical and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA. eminikel@broadinstitute.org.
• ⁵ Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA, USA. eminikel@broadinstitute.org.
• ⁶ Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, USA. eminikel@broadinstitute.org.
• ⁷ Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. eminikel@broadinstitute.org.
• ⁸ Prion Alliance, Cambridge, MA, USA. eminikel@broadinstitute.org.
• ⁹ Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
• ¹⁰ Analytical and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
• ¹¹ Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK.
• ¹² Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA, USA.
• ¹³ National Heart and Lung Institute and MRC London Institute of Medical Sciences, Imperial College London, London, UK.
• ¹⁴ Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London and Barts Health NHS Trust, London, UK.
• ¹⁵ School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
• ¹⁶ Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
• ¹⁷ Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
• ¹⁸ Department of Chemistry & Chemical Biology, Harvard University, Cambridge, MA, USA.
• ¹⁹ Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA. d.macarthur@garvan.org.au.
• ²⁰ Analytical and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA. d.macarthur@garvan.org.au.
• ²¹ Centre for Population Genomics, Garvan Institute of Medical Research and UNSW Sydney, Sydney, Australia. d.macarthur@garvan.org.au.
• ²² Centre for Population Genomics, Murdoch Children's Research Institute, Melbourne, Australia. d.macarthur@garvan.org.au.